Basit öğe kaydını göster

dc.contributor.authorDalkiran, M.
dc.contributor.authorKeles, I.
dc.contributor.authorSamim, S.
dc.contributor.authorBalcioglu, I.
dc.contributor.authorYildirim, E.
dc.contributor.authorEmul, M.
dc.contributor.authorBayar, R.
dc.date.accessioned2021-03-05T20:56:26Z
dc.date.available2021-03-05T20:56:26Z
dc.date.issued2009
dc.identifier.citationEmul M., Dalkiran M., Samim S., Yildirim E., Bayar R., Balcioglu I., Keles I., "The influences of depression and venlafaxine use at therapeutic doses on atrial conduction", JOURNAL OF PSYCHOPHARMACOLOGY, cilt.23, ss.163-167, 2009
dc.identifier.issn0269-8811
dc.identifier.otherav_d687809c-a876-4693-8f93-3631ccb79cb0
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/141568
dc.identifier.urihttps://doi.org/10.1177/0269881108089590
dc.description.abstractPatients with depression have increases risk of cardiac mortality. Overdose with venlafaxine has been accused of supraventricular tachycardia, atrial fibrillation and other cardiac effects. Discontinuous and inhomogeneous propagation of sinus impulses in atrium plays a major role in atrial fibrillation. We aimed to measure the effects of venlafaxine therapy on propagation of sinus impulses reflections in electrocardiography in depression. Eligible 19 participants were outpatients with depression. 75 mg/day dose of venlafaxine was administered to the patients. The patients were asked to complete both Beck Depression and Anxiety Inventories. 17 healthy participants enrolled in the study. The electrocardiography records were obtained while patients were drug naive and one week after treatment. The baseline durations of P(minimum) and P(maximum) in the patient group were significantly shorter than controls (p < 0,05). The differences between baseline and after venlafaxine therapy among electrocardiographical variables were statistically insignificant. There were no significant correlations between age, sex, body mass index, clinical inventories and electrocardiographical variables in both patients and controls. Autonomic dysregulation in myocardium is still inconclusive in depression. Venlafaxine at therapeutic dose of 75 mg/day does not seem to be associated with myocardial conduction dysregulation.
dc.language.isoeng
dc.subjectTıp
dc.subjectKLİNİK NEUROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectNEUROSCIENCES
dc.subjectSinirbilim ve Davranış
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectPsikiyatri
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNöroloji
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titleThe influences of depression and venlafaxine use at therapeutic doses on atrial conduction
dc.typeMakale
dc.relation.journalJOURNAL OF PSYCHOPHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume23
dc.identifier.issue2
dc.identifier.startpage163
dc.identifier.endpage167
dc.contributor.firstauthorID191712


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster